# ClinicalTrials.gov record history: NCT00004635

- Peptide profile: [leuprolide](https://peptidescanner.com/peptides/leuprolide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct00004635-leuprolide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct00004635.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `8bf9738ff1838e5fea1c2f9cad9dceddc40f70d501514d7270dd4b4ebf115a13`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2005-06-23 | 2005-06-23 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=1&tab=history) | `59605da1f4191839e51fa8e3e3e40c0f15246df2918b7c3bf3cc77959089cb99` |
| 2 | 2006-06-19 | 2006-06-19 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Eligibility, References, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=2&tab=history) | `051f93dd380b6a44da05313fcac9e9363efb41855c5cc097d9adb8c24addd22f` |
| 3 | 2010-07-01 | 2010-07-01 | COMPLETED | INTERVENTIONAL | Arms and Interventions, Contacts/Locations, Eligibility, References, Sponsor/Collaborators, Study Description, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=3&tab=history) | `2beb6318ecad46772162714f72ce35fe374e6378151b18a0e377ec448a467b7f` |
| 4 | 2010-09-17 | 2010-09-17 | COMPLETED | INTERVENTIONAL | References, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=4&tab=history) | `71d062d874747e875e794c441eab23183f2a5dc72830ab18f9d3805e13c74f71` |
| 5 | 2011-01-20 | 2011-01-20 | COMPLETED | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=5&tab=history) | `80023cbf2427e73cc383066951da6c82282146be996f0828a2dbaa81b21d97b8` |
| 6 | 2012-08-13 | 2012-08-13 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, Contacts/Locations, Eligibility, Limitations and Caveats, More Information, Outcome Measures, Outcome Measures (Results), Oversight, Participant Flow, References, Sponsor/Collaborators, Study Description, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=6&tab=history) | `d8b2393eb84157305e2db81e9260da902b77aaf8ad0ecfff578010d0daeddccf` |
| 7 | 2018-04-13 | 2018-04-13 | COMPLETED | INTERVENTIONAL | Adverse Events, Baseline Characteristics, Document Section, IPDSharing, Outcome Measures, Outcome Measures (Results), Oversight, Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT00004635?a=7&tab=history) | `fd44d4b687c024a277dc8692c1005d8d8083fc75f231e98bb9099f92f1498a38` |